Processing speed influences memory rehabilitation outcomes in TBI patients

Scientists at Kessler Foundation reported results from a randomized controlled trial examining the influence of processing speed on treatment benefits of the Kessler Foundation modified Story Memory Technique (KF-mSMT) in individuals with moderate to severe traumatic brain injury (TBI).

New 3D model mimics brain cell and immune cell interactions in Alzheimer’s disease

Cognitive decline associated with Alzheimer’s disease (AD) develops when neurons begin to die, which can be caused by inappropriate immune responses and excessive inflammation in

August 25, 2023

New computational method developed for linking DNA marks to gene activity

Scientists at La Jolla Institute for Immunology (LJI) have developed a new computational method for linking molecular marks on our DNA to gene activity.

June 4, 2024

Sanofi’s $1.7B rare disease gambit; CAR-T boxed warning saga; New biotechs on Nasdaq; A seller’s market for M&A?; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

January 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.